Clinical reference Biomarker Directory
Back to directory

Neurotensin

Emerging

Neurotensin is elevated in certain GI neuroendocrine tumors; its receptor is an emerging target for radioligand cancer therapy.

Also known as Neurotensin NT
In plain language

Neurotensin is a gut/brain hormone that's elevated in some rare digestive tumors. Researchers are also exploring whether its receptor could be used to specifically target certain cancers with radioactive treatment, similar to approaches already used for other neuroendocrine tumors.

Biomarker & context

Neurotensin is a gut/brain peptide hormone involved in digestive regulation and neurotransmission, with growing research relevance to certain neuroendocrine tumors.

What it indicates

Elevated levels are seen in certain gastrointestinal neuroendocrine tumors; neurotensin receptor expression is also being explored as a potential target for tumor-directed therapy in select cancers.

Diagnosis & clinical testing

Not a standardized diagnostic blood test in routine practice; measured primarily in research settings or specialized neuroendocrine tumor centers.

Guiding treatment

Neurotensin receptor signaling is an active area of cancer research, including neurotensin-receptor-targeted radioligand therapy in early clinical trials for pancreatic cancer, following a similar model to other peptide-receptor radionuclide therapies used in neuroendocrine oncology.

Clinical significance

Not yet a standardized diagnostic test; primarily relevant in specialized neuroendocrine tumor research and early clinical trials.

References
  1. General oncology reference literature on neurotensin receptor-targeted therapy research in neuroendocrine and pancreatic tumors.